Flow cytometry: a flexible tool for biomarker research.

Flow cytometry is increasingly recognized as an invaluable technology in biomarker research. Owing to its multiparametric nature it can provide highly detailed information on any single cell in a heterogeneous population. Its versatility means it can be conducted in both the preclinical and clinical setting, generating biomarker data that can drive decisions pertaining to dose selection in clinical trials, treatment options for cancer sufferers and even suitability of patients to receive transplants. Most tissue types can be utilized by the flow cytometrist, allowing the technology to be applied to many fields of research, yet consensus still needs to be reached on standardization, regulation and validation of multiparametric flow cytometry assays. In parallel, continual innovation in analysis software to manage the huge datasets that can be generated is also needed. Nevertheless, the flexibility of flow cytometry means that it remains at the forefront of both routine and exploratory biomarker studies.

[1]  D. DeMets,et al.  Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework , 2001, Clinical pharmacology and therapeutics.

[2]  Sean C. Bendall,et al.  Cytometry by time-of-flight shows combinatorial cytokine expression and virus-specific cell niches within a continuum of CD8+ T cell phenotypes. , 2012, Immunity.

[3]  Ray Liu,et al.  Validation of a flow cytometry based G(2)M delay cell cycle assay for use in evaluating the pharmacodynamic response to Aurora A inhibition. , 2011, JIM - Journal of Immunological Methods.

[4]  A Orfao,et al.  EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes , 2012, Leukemia.

[5]  W. Weimar,et al.  Phosphospecific flow cytometry for pharmacodynamic drug monitoring: analysis of the JAK-STAT signaling pathway. , 2012, Clinica chimica acta; international journal of clinical chemistry.

[6]  L. Picker,et al.  Naïve and memory B cells in the rhesus macaque can be differentiated by surface expression of CD27 and have differential responses to CD40 ligation. , 2011, Journal of immunological methods.

[7]  R. Kaul,et al.  Characterization of a Human Cervical CD4+ T Cell Subset Coexpressing Multiple Markers of HIV Susceptibility , 2011, The Journal of Immunology.

[8]  E. Molto,et al.  Assessment of immunological markers as mediators of graft vasculopathy development in heart transplantation. , 2011, Transplantation proceedings.

[9]  A. Sánchez‐Fueyo,et al.  Biomarkers of immunoregulatory status in stable liver transplant recipients undergoing weaning of immunosuppressive therapy. , 2010, Clinical immunology.

[10]  G. Nolan.  Flow cytometry in the post fluorescence era. , 2011, Best practice & research. Clinical haematology.

[11]  G. Janossy,et al.  From research tool to routine test: CD38 monitoring in HIV patients , 2009, Cytometry. Part B, Clinical cytometry.

[12]  M. Dougados,et al.  Blood memory B cells are disturbed and predict the response to rituximab in patients with rheumatoid arthritis. , 2011, Arthritis and rheumatism.

[13]  Peter Sutovsky,et al.  Application Note : New Instrumentation High Throughput , Parallel Imaging and Biomarker Quantification of Human Spermatozoa by ImageStream Flow Cytometry , 2009 .

[14]  T. Wyant,et al.  Validation of a flow cytometry based chemokine internalization assay for use in evaluating the pharmacodynamic response to a receptor antagonist , 2008, Journal of Translational Medicine.

[15]  R. Tal-Singer,et al.  SB-656933, a novel CXCR2 selective antagonist, inhibits ex vivo neutrophil activation and ozone-induced airway inflammation in humans. , 2011, British journal of clinical pharmacology.

[16]  F. Craig,et al.  Flow cytometric immunophenotyping for hematologic neoplasms. , 2008, Blood.

[17]  William A. Sewell,et al.  Polychromatic flow cytometry in the clinical laboratory , 2011, Pathology.

[18]  Marina Ruggeri,et al.  Report of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma and related disorders , 2008, Haematologica.

[19]  Wade T Rogers,et al.  Analysis of B cell subsets following pancreatic islet cell transplantation in a patient with type 1 diabetes by cytometric fingerprinting. , 2011, Journal of immunological methods.

[20]  Y. Vugmeyster,et al.  B‐cell subsets in blood and lymphoid organs in Macaca fascicularis , 2004, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[21]  Carla G Hill,et al.  Development and validation of flow cytometry methods for pharmacodynamic clinical biomarkers. , 2010, Bioanalysis.

[22]  Garry P Nolan,et al.  Fluorescent cell barcoding in flow cytometry allows high-throughput drug screening and signaling profiling , 2006, Nature Methods.

[23]  M. Stetler-Stevenson,et al.  Role of flow cytometry of peripheral blood and bone marrow aspirates in early myeloma. , 2011, Seminars in hematology.

[24]  M. Fishbein,et al.  Phosphorylated S6 Ribosomal Protein: A Novel Biomarker of Antibody‐Mediated Rejection in Heart Allografts , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[25]  G. Feuerstein,et al.  Translational medicine for stroke drug discovery: the pharmaceutical industry perspective. , 2009, Stroke.

[26]  E. Herrmann,et al.  Interleukin-2 in CD8+ T cells correlates with Banff score during organ rejection in liver transplant recipients , 2009, Clinical and Experimental Medicine.

[27]  K. Williams,et al.  Immunophenotyping of lymphocyte, monocyte and dendritic cell subsets in normal rhesus macaques by 12-color flow cytometry: clarification on DC heterogeneity. , 2010, Journal of immunological methods.

[28]  L. Kumar,et al.  Flow cytometric immunophenotyping and minimal residual disease analysis in multiple myeloma. , 2009, American journal of clinical pathology.

[29]  B. Walker,et al.  Flow cytometric methods for prenatal and neonatal diagnosis. , 2011, Journal of immunological methods.

[30]  B. Panaszek,et al.  A new variant of the basophil activation test for allergen-induced basophil CD63 upregulation. The effect of cetirizine. , 2009, Journal of investigational allergology & clinical immunology.

[31]  Mario Roederer,et al.  A chromatic explosion: the development and future of multiparameter flow cytometry , 2008, Immunology.

[32]  L Findlay,et al.  Monoclonal antibody TGN1412 trial failure explained by species differences in CD28 expression on CD4+ effector memory T‐cells , 2010, British journal of pharmacology.

[33]  K. Ley,et al.  Neutrophil Adhesion and Activation under Flow , 2009, Microcirculation.

[34]  E. Waller,et al.  Translational Applications of Flow Cytometry in Clinical Practice , 2012, The Journal of Immunology.

[35]  H. Harmouche,et al.  Evaluation of a dry format reagent alternative for CD4 T‐cell enumeration for the FACSCount system: A report on a Moroccan–Canadian study , 2009, Cytometry. Part B, Clinical cytometry.

[36]  M. Dieterlen,et al.  Flow cytometry-based pharmacodynamic monitoring after organ transplantation. , 2011, Methods in cell biology.

[37]  N. Frangogiannis,et al.  Biomarkers: hopes and challenges in the path from discovery to clinical practice. , 2012, Translational research : the journal of laboratory and clinical medicine.

[38]  C. Mowbray,et al.  Challenges of drug discovery in novel target space. The discovery and evaluation of PF-3893787: a novel histamine H4 receptor antagonist. , 2011, Bioorganic & medicinal chemistry letters.

[39]  R. Balderas,et al.  Modulation of Cell Signaling Networks after CTLA4 Blockade in Patients with Metastatic Melanoma , 2010, PloS one.

[40]  D. Dorfman,et al.  Single tube, six-color flow cytometric analysis is a sensitive and cost-effective technique for assaying clonal plasma cells. , 2010, American Journal of Clinical Pathology.

[41]  C. Gray,et al.  FOXP3 Expression Is Upregulated in CD4+T Cells in Progressive HIV-1 Infection and Is a Marker of Disease Severity , 2010, PloS one.

[42]  Luc Kestens,et al.  Evaluation of a flow cytometry method for CD4 T cell enumeration based on volumetric primary CD4 gating using thermoresistant reagents. , 2011, Journal of immunological methods.

[43]  Ashley T. Haase,et al.  Targeting early infection to prevent HIV-1 mucosal transmission , 2010, Nature.

[44]  D. Parkinson,et al.  Single-cell network profiling (SCNP) by flow cytometry in autoimmune disease , 2010, Autoimmunity.

[45]  Richard Houghton,et al.  Conference Report: Analytical challenges in the qualification and validation of pharmacodynamic biomarkers. , 2011, Bioanalysis.

[46]  F. Mohr,et al.  Assay validation of phosphorylated S6 ribosomal protein for a pharmacodynamic monitoring of mTOR‐inhibitors in peripheral human blood , 2012, Cytometry. Part B, Clinical cytometry.

[47]  Phospho-specific Flow: Fixating on the Target , 2012, Clinical Cancer Research.

[48]  G. Janossy,et al.  CD8/CD38 activation yields important clinical information of effective antiretroviral therapy: Findings from the first year of the CIPRA‐SA cohort , 2008, Cytometry. Part B, Clinical cytometry.

[49]  Sean C. Bendall,et al.  Single-Cell Mass Cytometry of Differential Immune and Drug Responses Across a Human Hematopoietic Continuum , 2011, Science.

[50]  M. Inngjerdingen,et al.  Natural killer cell subsets in man and rodents. , 2011, Tissue antigens.

[51]  F. León.  Flow cytometry of intestinal intraepithelial lymphocytes in celiac disease. , 2011, Journal of immunological methods.

[52]  Volker Budach,et al.  A simple multicolor flow cytometry protocol for detection and molecular characterization of circulating tumor cells in epithelial cancers , 2012, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[53]  A. V. van Gool,et al.  From biomarker strategies to biomarker activities and back. , 2010, Drug discovery today.

[54]  M. Fort,et al.  Determination of Absolute Counts of Circulating Regulatory T Cells in Cynomolgus Macaques Using an Optimized Flow Cytometric Method , 2012, Toxicologic pathology.

[55]  A. Órfão,et al.  Multiparameter flow cytometric remission is the most relevant prognostic factor for multiple myeloma patients who undergo autologous stem cell transplantation. , 2008, Blood.

[56]  M. Picot,et al.  Close association of CD8+/CD38bright with HIV‐1 replication and complex relationship with CD4+ T‐cell count , 2009, Cytometry. Part B, Clinical cytometry.

[57]  Sean C. Bendall,et al.  A deep profiler's guide to cytometry. , 2012, Trends in immunology.

[58]  Pratip K. Chattopadhyay,et al.  Early immunologic correlates of HIV protection can be identified from computational analysis of complex multivariate T-cell flow cytometry assays , 2012, Bioinform..

[59]  Virginia Litwin,et al.  Recommendations for the validation of flow cytometric testing during drug development: II assays. , 2011, Journal of immunological methods.